Abstract. The aim of the present study was to investigate the differences in biological characteristics between the rhodamine 123 (Rh123) high and Rh123 low subpopulations of the renal cancer cell line 786-O and to identify evidence for the existence of cancer stem cells in renal cell carcinoma (RCC) cells. In vitro cultured RCC 786-O cells were stained with Rh123, analyzed and sorted with flow cytometry. The differences in proliferative activity, long-term differentiation and radiation sensitivity between the two subpopulations were measured and the oncogenicity of each subpopulation was evaluated according to their neoplastic growth ability in soft agar and tumor-forming ability in NOD/SCID immunodeficient mice. There were two subpopulations in the cultured 786-O cells, Rh123 high and Rh123 low cells. Rh123 low cells were the majority among 786-O renal carcinoma cells and barely formed solid tumors in NOD/SCID mice and colonies in soft agar. By contrast, the Rh123 high cells were the minority, exhibited high proliferative activity, differentiation ability and resistance to radiation and showed high tumorigenesis potential and colony forming efficiency. The Rh123 high cells had stem-like characteristics in cultured RCC 786-O cells in vitro.
Introduction
Cancer stem cells (CSC), which have the ability to self-renew and differentiate, may contribute to tumor proliferation and recurrence following chemotherapy and radiotherapy. Currently, CSCs have become a key focus of tumor studies since they are expected to reveal biomarkers which may be de novo targets for tumor therapy. CSCs have already been identified in numerous tumor types, including breast (1), brain (2) , colon (3, 4) and prostate cancers (5) .
The ability of stem cells to efflux chemotherapeutic drugs and certain dyes, such as Hoechst 33342 and rhodamine 123 (Rh123) (6) , may be used to isolate cells with progenitor characteristics (7, 8) . Cells stained with such fluorescent dyes may present distinguishable subpopulations in flow cytometry profiles, allowing sorting for further biological studies. This technique provides an alternative approach to isolating progenitor cells through the use of specific surface markers and a feasible method for identifying putative tumor-initiating cells.
Rh123, a low toxicity fluorescent dye, is a mitochondrial dye that stains mitochondria with increasing intensity as cells become activated. It is able to detect reduced mitochondrial activation states in long-term quiescent cells. Decreased intracellular accumulations of Rh123 result from the efflux of the dye (9) .
Renal cell carcinoma (RCC) is a kidney cancer that originates from the proximal convoluted tubule. It is the most common type of kidney cancer in adults, responsible for ~80% of cases (10) . It is also known to be the most lethal of all the genitourinary tumors. RCC is resistant to radiation therapy and chemotherapy (11) . Thus, it is necessary to identify a CSC subpopulation in RCC, since screening and identifying RCC stem cells is likely to be of significance for prognosis and treatment. However, it is not yet clear whether there are CSCs in renal carcinoma. The aim of the present study was to isolate cancer stem-like cells from the renal carcinoma cell line 786-O using Rh123 staining and flow cytometry, and compare the various biological characteristics between subpopulations.
Materials and methods
Cell line and culture. The human renal cancer cell line 786-O was purchased from the Shanghai Cell Bank of Type Culture Collection (Chinese Academy of Sciences, Shanghai, China) and maintained in RPMI-1640 medium (Gibco, Grand Island, NY, USA) containing 10% heat-inactivated fetal bovine serum (FBS; Hyclone, Waltham, MA, USA), 100 U/ml penicillin G and 100 µg/ml streptomycin in a humidified 5% CO 2 incubator at 37˚C. low cells) were suspended in 2 ml of 0.35% melted agar in RPMI-1640 medium with 10% FBS and plated in 60-mm dishes containing a solidified bottom layer of 1.25% agar in the same medium. After 3 weeks, the number of colonies containing >50 cells was counted. The colony-forming efficiency (CFE) was calculated as the ratio of the colony number to the original number of cells seeded. The experiments were independently performed three times.
Long-term differentiation of Rh123
high and Rh123 low cells. The Rh123 high and Rh123 low cells were subcultured for 18 days after cell sorting. The cells were then stained separately with Rh123 and analyzed with a flow cytometer to quantitate the proportion of the Rh123 high subpopulation in each sorted group.
Radiation sensitivity assay. Freshly sorted Rh123
high and Rh123 low cells (2x10 5 ) were seeded in five culture flasks and the cells were irradiated with 0, 0.5, 1, 2 and 4 Gy of X-rays, The next day after radiation treatment, the cells were then harvested and seeded at various low densities into 35-mm dishes. All the cells were cultured under normal culture conditions (humidified 5% CO 2 incubator at 37˚C). After 10 days, when the majority of cell clones in the sham control group reached >50 cells, the dishes were stained with crystal violet to determine the plating efficiency. The experiments were independently performed three times.
Xenograft tumor. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice were purchased from Shanghai Slac Laboratory Animal Co. Ltd. (Shanghai, China) and maintained in micro isolator cages. All experiments were approved by the animal care committee of the Second Hospital of Lanzhou University. Freshly sorted Rh123 high and Rh123 low cells (1x10 7 , 1x10 6 or 1x10 5 cells/ml) were suspended in 200 µl PBS and then inoculated into the axillary fossa of six-week-old male NOD/SCID mice immediately after cell sorting. The mice were monitored twice a week for palpable tumor formation and euthanized when the tumors grew to appropriate sizes. Tumors were measured using a vernier caliper, weighed and photographed.
Cell surface marker screening. Freshly sorted Rh123 high and Rh123 low cells were incubated in RPMI-1640 for 2 days to reach the desired cell number. Then, the cultured cells were harvested and diluted to 1x10 6 cells/ml with PBS containing 5% FBS, and stained with Rh123 for 20 mins. The Rh123 positive staining cells were divided into multiple vials and each was probed with CD3-FITC, CD4-PE, CD8-PerCP, CD24-PE and CD44-FITC antibody for 30 min in the dark, then analyzed by FACS to quantitate the proportion of positive cells.
Statistical analysis. The SPSS 12.0 statistical software (SPSS Inc., Chicago, IL, USA) was used for the data processing and analyzing the significance of differences between the Rh123 high and Rh123 low cells using unpaired t-tests. P<0.05 was considered to indicate statistically significant differences. Data were expressed as the mean ± SD from at least three independent experiments.
Results

Rh123 staining and sorting of 786-O cells. 786-O cells stained
with Rh123 were observed under a fluorescence microscope. It was observed that a small fraction of the cells were stained green, namely the Rh123 high cells, while the majority presented no or extremely weak fluorescence, namely the Rh123 low cells (Fig. 1A) . In the flow cytometry profile, two distinguishable subpopulations were observed, Rh123 high and Rh123 low (Fig. 1B) Fig. 2A . The Rh123 high cells exhibited a similar proliferation rate to the unsorted cells and their doubling times were 21 and 18 h, respectively. However, the Rh123 low cells grew slowly and with a doubling time of 36 h.
In the colony formation assay, the same number of the three types of cells were seeded in soft agar and cultured for >3 weeks prior to colony counting. The results are shown in Fig. 2B and C. The majority of Rh123 high cell colonies were mulberry-like in appearance and the colony-forming efficiency (CFE) was 0.687±0.177%, while the Rh123 low cells did not produce significant cell colonies and their CFE was only 0.029±0.007%.
Long-term differentiation ability. The Rh123
high cells had a higher differentiation potential than the Rh123 low cells. As shown in Fig. 3 (Fig. 4) .
Radiosensitivity. When exposed to X-rays, the Rh123 high cells behaved similarly to unsorted cells and showed noticeably larger survival fractions compared with the Rh123 low cells (Fig. 5) .
Screening of surface markers. As shown in Fig. 6 , the two cell subpopulations and unsorted cells were positive for CD24 and CD44, but negative for CD3, CD4 and CD8. These cell surface markers were clearly not specific markers for RCC stem cells.
Discussion
RCC is a difficult malignancy to treat due to its ability to spread asymptomatically and its inherent resistance to radio- (12) . The identification of RCC stem cells is expected to provide a novel approach to solving this problem.
In the present study, cancer stem-like SPs were successfully derived from the human renal cancer cell line 786-O, using rhodamine 123 staining and sorting by flow cytometry. Notably, the Rh123 high SP cells were observed to have the basic characteristics of CSCs. It is generally considered that CSCs exist in Rh123 low subgroups (13, 14) , although the present results demonstrated the opposite of this. By using flow cytometry after Rh123 staining, human cervical carcinoma HeLa, hepatoma HepG2, melanoma OCM-1 and gastric cancer MGC-803 cells were analyzed and the results were consistent with the published literature. The proportion of Rh123 low cells in each cell line was <5% (data not shown). However, human renal cancer cells were different from these tumors. In in vitro cultured RCC 786-O cells, the Rh123 high SP cells were less common than the Rh123 low subgroup and the tumorigenic capacity of Rh123 low SP cells was less than that of the Rh123 high cells. These results suggest that the biological characteristics of RCC may differ from carcinomas originating from other tissues.
CSCs theoretically have unlimited proliferative ability, self-renewal capacity and multi-differentiation potential, which drives tumor formation and growth (13) . In the present study, the Rh123 high subpopulation of RCC 786-O cells was demonstrated to be capable of driving tumor formation and growth. The growth characteristics (Fig. 2) , tumorigenesis (Fig. 3) , differentiation potential (Fig. 4) and radiotherapy resistance (Fig. 5) suggested that the Rh123 high subpopulation has RCC stem cell-like characteristics.
Bussolati et al (15) observed that the mesenchymal stem cell marker CD105-positive cells present in human renal carcinomas were the renal tumor-initiating cell population. However, CD105 expression was not observed on the surface of 786-O cells (data not shown). Pode-Shakked (16) observed that NCAM was a putative marker for the Wilms' tumor Cells were collected, diluted and plated at low density into 35-mm dishes. After 10 days, the cells were fixed, stained and counted. Each experiment was independently repeated three times. Rh123, rhodamine 123.
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stem/progenitor cell population, although we have not studied whether NCAM is expressed in RCC cells. In the present study, the cell surface markers CD3, CD4, CD8, CD24 and CD44 were excluded as stem cell markers for RCC (Fig. 6 ).
Further characterization of the RCC Rh123 high cells, by studying clinical RCC specimens and screening for surface markers, is likely to have an impact on their clinical application. 
